Grant: Discovery Grants Program - Individual
University of British Columbia
$28,000.00
Advanced Methods to Study Proteome Dynamics at Molecular and Cellular Resolution
FY 2015-16
Summary
Technological advances in mass spectrometry now make it possible to rapidly map simple proteomes such as that of the unicellular organism yeast. The human proteome is more complex, however: two added levels of complexity involve an array of post-translational modifications (PTMs) that affect protein function and the existence of distinct cell types that form tissues and organs. The recent progress makes these levels also accessible to proteomics, enabling new areas of application such as drug research. This field has seen the renaissance of screening techniques that rely on reproducing a particular phenotype of a disease, which helps identify new drug target families. Generating a particular disease phenotype is not trivial, and proteomics can help qualify phenotypic models to facilitate their development, but also provide functional insights for drug target identification.
This proposal will focus on the development of novel, integrated proteomics methods that can be used for this purpose. Human blood platelets and other cells with which they engage in physiological or pathological interactions, an established model in our laboratory that has led to significant recent progress, will be used to work on four distinct themes: 1) the integration of multiple sub-proteomes to achieve more comprehensive coverage of cellular function - this will see the development and integration of a variety of PTM enrichment strategies, their integration into a workflow that matches functional changes of cells, and the inclusion of formaldehyde cross-linking to follow up on the interactions of proteins of interest; 2) increasing the throughput of proteomic analyses to assess proteome dynamics - this will involve the introduction of hyperplexing strategies to analyze a large number of conditions in parallel, and the optimization of sample preparation and separation strategies; 3) defining the changes on the individual cell level - this will take advantage of the highly multiplexed profiling technique mass cytometry that enables deep profiling of complex cell mixtures such as blood; and 4) the development of multi-cell type models that resemble blood and blood vessels, and allow the unbiased analysis of functional changes by proteomics and MALDI and tissue imaging. Together, these themes will significantly advance proteomics research and enable its use in new areas of biomedical and drug research.
Program
Discovery Grants Program - Individual
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2015-04839
Name nom
Kast, Juergen
Department département
Biomedical Research Centre (The) - Biomedical Research Centre (The)
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
28000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Partie
1
Nb partie
1
Application title
Advanced Methods to Study Proteome Dynamics at Molecular and Cellular Resolution
Keyword
NSERC
Application summary
Technological advances in mass spectrometry now make it possible to rapidly map simple proteomes such as that of the unicellular organism yeast. The human proteome is more complex, however: two added levels of complexity involve an array of post-translational modifications (PTMs) that affect protein function and the existence of distinct cell types that form tissues and organs. The recent progress makes these levels also accessible to proteomics, enabling new areas of application such as drug research. This field has seen the renaissance of screening techniques that rely on reproducing a particular phenotype of a disease, which helps identify new drug target families. Generating a particular disease phenotype is not trivial, and proteomics can help qualify phenotypic models to facilitate their development, but also provide functional insights for drug target identification. <br />
<br />
This proposal will focus on the development of novel, integrated proteomics methods that can be used for this purpose. Human blood platelets and other cells with which they engage in physiological or pathological interactions, an established model in our laboratory that has led to significant recent progress, will be used to work on four distinct themes: 1) the integration of multiple sub-proteomes to achieve more comprehensive coverage of cellular function - this will see the development and integration of a variety of PTM enrichment strategies, their integration into a workflow that matches functional changes of cells, and the inclusion of formaldehyde cross-linking to follow up on the interactions of proteins of interest; 2) increasing the throughput of proteomic analyses to assess proteome dynamics - this will involve the introduction of hyperplexing strategies to analyze a large number of conditions in parallel, and the optimization of sample preparation and separation strategies; 3) defining the changes on the individual cell level - this will take advantage of the highly multiplexed profiling technique mass cytometry that enables deep profiling of complex cell mixtures such as blood; and 4) the development of multi-cell type models that resemble blood and blood vessels, and allow the unbiased analysis of functional changes by proteomics and MALDI and tissue imaging. Together, these themes will significantly advance proteomics research and enable its use in new areas of biomedical and drug research.